FDA panel: Approve the ‘bionic eye’, with conditions

Second Sight's Argus II bionic eye

An FDA advisory panel recommended that the federal watchdog agency grant a humanitarian device exemption to Second Sight Medical Products’ Argus II retinal prosthesis system, designed for patients who are profoundly blind due to a rare condition called retinitis pigmentosa.

Patients with retinitis pigmentosa have either bare light perception or none at all. There is currently no cure and no available treatment for the rare condition that’s diagnosed about 250 times each year.

The Ophthalmic Devices Panel’s recommendation, which the FDA is not obliged to follow, came with a caveat: Second Sight should be compelled to run a rigorous post-approval study because of the significant risks posed by the device.

A majority of panelists, 17-2, agreed that Argus II demonstrated a reasonable assurance of safety even though different versions of two device configurations were implanted in 30 subjects in the clinical trial; no subjects were implanted with the version of the device proposed for marketing because modifications were made to the implant’s application specific circuit chip, suture tab and carrier frequency; the testing was non-randomized; evaluators were unmasked; numerous modifications were made to the study protocol during the course of study; and there were a number of protocol deviations.

Indiana School of Optometry’s William Swanson cast dissenting votes on the questions of safety and reasonable assurance of probable benefit, though he agreed the probable benefits outweighed the risks.

"There are people who are not going to benefit; we don’t know who they are. There are people who are going to lose their eye, there are some people who are going to lose 2 eyes," Swanson said. "So I really couldn’t say it was safe and I couldn’t say it was effective, but I do feel that for the patient population at risk, there is a possible benefit, even though it’s not for everybody."

Swanson suggested that the patient brochure not oversell Argus II and that it more directly inform patients of the adverse events experienced by patients in the clinical trial.

"I think it’s important to emphasize that this will provide low vision rather than some, partial vision," said Alvin Eisner of Northwest Sarcoma Foundation. "The expectations have to be realistic."

The data show that with the Argus II "mobility is not really clear, but orientation seems to be something that is the greatest benefit … and as we’ve heard, orientation (knowing where you and others are in space) is extremely important, even if it doesn’t help you walk," Swanson noted.

The panel agreed on a 5-to-10-year post-approval study including both follow-up of patients in whom the device has already been implanted and a well-controlled study of a new group of patients. Safety, stability and utility topped the list of concerns.

Panelists asked that the post-approval study include a close assessment of adverse events, reliability of the Argus II device, visual function measures and some quality assurance controls related to measurements of those assessments.

"We really need to have a careful recording of what the adverse events truly are, because the evaluation of the adverse events, whether they are serious or not serious, was sort of somewhat flippantly done in the past," stressed Saint Louis University School of Medicine’s Dr. Stephen Feman. "There was a patient, for example, recorded who went blind. That was not listed as a serious adverse event because the patient went blind in both eyes … yet some might say that’s a serious adverse event. Maybe the intervention caused the blindness in both eyes."

RSS From Medical Design & Outsourcing

  • Rotary drum coating technology conquers the market
    More and more customers are choosing the rotary drum technology for coating their mass-produced small plastic and rubber components. Within just a few years the sales of the Walther Trowal Rotamat coating systems have increased several fold. At the DKT/IRC 2015 the company is introducing its redesigned Rotamat R80, which compared to its predecessor model […]
  • Glebar focuses on Arthroscopic Shaver market
    A new arthroscopic shaver application, developed by Glebar Company for its advanced GT-610 CNC centerless grinder, is now delivering the most precise inner and outer tubes for use by orthopedic surgeons.The first two systems equipped with the innovative application have been sold to a major manufacturer of arthroscopic shavers.  The system will be on display […]
  • Read your ELISA plates from anywhere
    Now you can read your ELISA plate with an iOS or Android tablet or cell phone. The Enzo ELISA Plate Reader app is provided by Enzo Life Sciences as a tool to enable the use of colorimetric plate based assays in a wider variety of environmental settings. The plate reader application can provide quantitative results […]
  • A robotics startup that makes mosaics targets prescription pills
    To the average customer, it would seem strange why a mosaic manufacturing business would be doing research into organizing prescription pills. But to Ted Acworth, founder and CEO of Artaic, the businesses have striking similarities that lie in the company’s software design and robotics. “If you extract it, as we can with our computer and […]
  • Medical part designs fabricated by Acme Metal Spinning
    Medical designers needing custom conical, hemispherical and cylindrical metal components have an ideal option from Acme Metal Spinning. Using the metal spinning process, Acme seamlessly forms flat metal discs and pre-formed metal work pieces on CNC metal spinning lathes into components for medical device and equipment assemblies. Custom shaped parts range from cones, flanges, spools […]
  • MedPharmPlast Conference excites attendees
    On June 23, this year’s MedPharmPlast Europe Conference will bring together leaders and experts from the whole European medical devices and pharmaceutical packaging supply chain at the Clariant Innovation Center in Frankfurt. In three sessions, participants will get an expert update on the current most important topics concerning the medical devices and packaging industry on EU […]
  • 1200 to attend Joint Congress on Medical Imaging and Radiation Sciences
    Montreal, Quebec, will be the site of an unprecedented gathering of over 1200 medical imaging and radiation therapy specialists, at the 2015 Joint Congress on Medical Imaging and Radiation Sciences, May 28-30, 2015. They have come from all points of the globe; the United States, the United Kingdom. France, Cameroon, Guadeloupe, Trinidad and Tobago, Turkey, […]
  • KNF Neuberger adds powerful, compact OEM pumps
    KNF Neuberger, Inc. announces an extension to the line of brushless DC powered NFB boxer pumps with the addition of two compact models. The new NFB 5 and NFB 25 feature low pulsation, gentle transfer of liquids from 5 – 300 mL/min per head, and cost savings thanks to efficient design and long product life. […]
  • MSC Software’s MaterialCenter 2015 delivers material data integration
    MSC Software announced the new release of MaterialCenter 2015. MaterialCenter 2015 is a truly out-of-the-box Material Process and Data Lifecycle Management solution with direct integration into CAE applications that engineers regularly use.     CAE Material Model Support Generate CAE models for the most popular CAE solver directly from MaterialCenter. Support for individual and batch generation […]
  • Exploring a new frontier of cyber-physical systems: The human body
    The National Science Foundation (NSF) announced two, five-year, center-scale awards totaling $8.75 mil to advance the state-of-the-art in medical and cyber-physical systems (CPS). One project will develop “Cyberheart”—a platform for virtual, patient-specific human heart models and associated device therapies that can be used to improve and accelerate medical-device development and testing. The other project will […]
  • DeNovo Sciences signs a collaboration agreement to use CTCs for whole genome sequencing
    DeNovo Sciences announced a collaborative research agreement with START (South Texas Accelerated Research Therapeutics) a San Antonio based Phase I medical oncology program, one of the world’s largest of its kind with clinical trial sites on three continents. According to the deal, START will collect blood from cancer patients and use DeNovo instruments and reagents for […]
  • Enfield Technologies introduces a leap forward in Miniature Proportional Valves
    Enfield Technologies introduced the new PFV family of Enfield 2/2 proportional valves for variable liquid and gas flow. Some key differentiating features are: Incredibly Low Hysteresis (±5 %) Consistent opening voltage/current from valve-to-valve (each valve is calibrated and “locked-in”) Submersible/Wash-down – Check out the video below for two valves in a fish tank. Stainless Steel […]
  • Eight pieces of Medical Technology that improved patient care outcomes
    At Modular Devices, we’re passionate about helping our clients improve the care and experience their patients receive at facilities across the country. We’re thrilled to have played a role in reducing the death rates related to heart disease since the early days of our company in the late 1980’s. As part of Heart Disease Awareness […]
  • Medtech startups outsource R&D
    Starting a medtech company comes with a host of challenges, from regulation to financing to reimbursement. One way that companies can overcome those challenges, according to 2 industry experts, is to outsource some of the research and development work – and in the process, create a leaner, more flexible company. The executives spoke at the […]
  • Excelsys Xsolo power supplies meet medical performance specifications
    Excelsys Technologies announced that its Xsolo power supplies have been designed and tested to meet both the B and BF type requirements per the IEC 60601 standard.  This makes them suitable for applications that need these levels of performance for power supplies used in medical applications. Excelsys’ testing procedures were performed in accordance with requirements […]